ARTICLE | Company News
Max Planck Society, Lead Discovery Center and Daiichi partner to discover cancer compounds
July 21, 2017 6:48 PM UTC
Max Planck Society (Munich, Germany) and Lead Discovery Center GmbH (Dortmund, Germany) and Daiichi Sankyo Co. Ltd. (Tokyo:4568) partnered to discover and optimize highly selective kinase inhibitors that target cancer cell transcription and proliferation. Max Planck and Daiichi will fund the discovery portion of the deal at the Lead Discovery Center...